Study | Continent | Design | Number of Lesions | Setting | Index test (Strain Ratio) Measurement Method | Reference Standard | Target Condition Definition |
---|---|---|---|---|---|---|---|
Ahmed 2020Â [14] | Africa | Prospective | 132 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Alhabshi 2013Â [15] | Asia | Prospective | 168 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Arslan 2018Â [16] | Europe | Retrospective | 113 | Imaging before biopsy | Not Clear | Mixed | Malignant Vs Benign |
Balcik 2016Â [17] | Europe | Prospective | 135 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Bojanic 2017Â [18] | Europe | Prospective | 130 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Chee 1Â 2019 [19] | Asia | Prospective | 53 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Chee 2Â 2019 [19] | Asia | Prospective | 53 | Imaging before biopsy | GLR | Mixed | Malignant Vs Benign |
Cheng 2018Â [20] | Asia | Prospective | 37 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Cho 2010Â [21] | Asia | Prospective | 99 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Dawood 2018Â [22] | Africa | Prospective | 40 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Fausto 2015Â [23] | Europe | Prospective | 129 | Imaging before biopsy | Mixed FLR and GLR | Core Biopsy | Malignant Vs Benign |
Fujioka 2019Â [24] | Asia | Retrospective | 148 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Gheonea 2011Â [25] | Europe | Prospective | 58 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Gong 2013Â [26] | Asia | Prospective | 192 | Imaging before biopsy | Not Clear | Mixed | Malignant Vs Benign |
Graziano 1Â 2017 [27] | South America | Prospective | 159 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Graziano 2Â 2017 [27] | South America | Prospective | 159 | Imaging before biopsy | GLR | Mixed | Malignant Vs Benign |
Guruf 2019Â [28] | Europe | Prospective | 87 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Hao 2020Â [29] | Asia | Prospective | 311 | Imaging before biopsy | GLR | Mixed | Malignant Vs Benign |
Jung Hahn 2012Â [30] | Asia | Retrospective | 110 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Jung Park 1Â 2016Â [31] | Asia | Prospective | 358 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Jung Park 2Â 2016Â [31] | Asia | Prospective | 358 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Khamis 2017Â [32] | Africa | Prospective | 120 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Kim Kim 2018Â [33] | Asia | Prospective | 108 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Kumm 2010Â [34] | North America | Prospective | 310 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Lee 2011Â [35] | Asia | Retrospective | 315 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Li Wang 2015Â [36] | Asia | Retrospective | 89 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Liu 2014Â [37] | Asia | Retrospective | 431 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Mansour 2012Â [38] | Africa | Prospective | 97 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Menezes 2016Â [39] | Asia | Prospective | 143 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Mu 2016Â [40] | Asia | Retrospective | 1080 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Mutala 2016Â [41] | Africa | Prospective | 112 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Nakashima 2018Â [42] | Asia | Prospective | 232 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Ozel 2018Â [43] | Europe | Prospective | 297 | Imaging before biopsy | Mixed FLR and GLR | Core Biopsy | Malignant Vs Benign |
Ozsoy 2016Â [44] | Europe | Prospective | 168 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Parajuly 2012Â [45] | Asia | Prospective | 342 | Imaging before biopsy | Not Clear | Mixed | Malignant Vs Benign |
Park 1Â 2020Â [46] | Asia | Retrospective | 140 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Park 2Â 2020Â [46] | Asia | Retrospective | 140 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Park 3Â 2020Â [46] | Asia | Retrospective | 140 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Rehman 2017Â [47] | Asia | Prospective | 137 | Imaging before biopsy | Not Clear | Core Biopsy | Malignant Vs Benign |
Ricci 2017Â [48] | Europe | Prospective | 242 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Seo 2018Â [49] | Asia | Prospective | 45 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Singla 2019Â [50] | Asia | Prospective | 199 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Stachs 2013Â [51] | Europe | Prospective | 224 | Imaging before biopsy | Not Clear | Not Clear | Malignant Vs Benign |
Stoian 2016Â [52] | Europe | Prospective | 174 | Imaging before biopsy | Not Clear | Surgical | Malignant Vs Benign |
Thomas 2010Â [53] | Europe | Prospective | 227 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Turker 2017Â [54] | Europe | Prospective | 75 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Ueno 1Â 2015[55] | Asia | Prospective | 98 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Ueno 2Â 2007Â [56] | Asia | Not Clear | 406 | Imaging before biopsy | Not Clear | Not Clear | Malignant Vs Benign |
Wang 2018Â [57] | Asia | Prospective | 302 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Yagci 2017Â [58] | Europe | Prospective | 68 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Yerli 2011[59] | Europe | Prospective | 78 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Yildiz 2020Â [60] | Europe | Prospective | 50 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Yilmaz 2017Â [61] | Europe | Prospective | 79 | Imaging before biopsy | FLR | Core Biopsy | Malignant Vs Benign |
Yoon 1Â 2016Â [62] | Asia | Prospective | 201 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Yoon 2Â 2017 [63] | Asia | Prospective | 243 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Yoon 3 2017Â [63] | Asia | Prospective | 243 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
You 2019Â [64] | Asia | Retrospective | 373 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Youk 2014Â [65] | Asia | Retrospective | 79 | Imaging before biopsy | Not Clear | Mixed | Malignant Vs Benign |
Zhang 1Â 2020Â [66] | Asia | Prospective | 91 | Imaging before biopsy | Mixed FLR and GLR | Not Clear | Malignant Vs Benign |
Zhang 2Â 2020Â [66] | Asia | Prospective | 91 | Imaging before biopsy | Mixed FLR and GLR | Not Clear | Malignant Vs Benign |
Zhao 2018Â [67] | Asia | Retrospective | 1071 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Zhi 2010Â [68] | Asia | Prospective | 559 | Imaging before biopsy | Mixed FLR and GLR | Mixed | Malignant Vs Benign |
Zhou 1Â 2014 [69] | Asia | Prospective | 193 | Imaging before biopsy | FLR | Mixed | Malignant Vs Benign |
Zhou 2Â 2014 [69] | Asia | Prospective | 193 | Imaging before biopsy | GLR | Mixed | Malignant Vs Benign |
Zhou 3Â 2014 [70] | Asia | Prospective | 127 | Imaging before biopsy | GLR | Mixed | Malignant Vs Benign |